Trials / Recruiting
RecruitingNCT04246463
Terumo Aortic Global Endovascular Registry
A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Vascutek Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.
Detailed description
Post Market registry collecting real world, post-approval safety, performance, patient reported outcomes and health economic data on patients treated with Terumo Aortic endovascular stent-grafts in standard clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thoracic | Implant of a Relay stent graft system |
| DEVICE | Abdominal | Implant with an Anaconda or Treo Stent graft system |
| DEVICE | Custom Device | Implant of a Fenestrated device such as Fenestrated Anaconda or Fenestrated TREO, Relay Branch or other customised device |
| DEVICE | Illiac Artery | Implant with an Anaconda Iliac leg only |
Timeline
- Start date
- 2019-12-17
- Primary completion
- 2029-11-01
- Completion
- 2030-11-01
- First posted
- 2020-01-29
- Last updated
- 2026-03-13
Locations
58 sites across 10 countries: United States, Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT04246463. Inclusion in this directory is not an endorsement.